positive
Recently
Sudeep Pharma IPO Sees Strong Day-2 Demand as GMP Hints at 20% Listing Premium
Sudeep Pharma’s IPO sees strong Day-2 demand with a GMP implying nearly 20% listing gains, backed by robust anchor participation and expansion plans.
Sudeep Pharma’s ₹895 crore IPO continued to gain traction on its second day after being fully subscribed on the opening day. The company raised ₹268.5 crore from anchor investors ahead of the issue, which is priced at ₹563–593 per share and closes on November 25. The offer comprises a ₹95 crore fresh issue and an ₹800 crore offer for sale.